In this study, the common immune checkpoints, including PDL1/2, LAG3, and CTLA4, were significantly upregulated in the high-risk AML population, which indicated an immunosuppressive TME of bone marrow in the high risk group (Figures 6B–F). This evidence concerns the gene CD274 and acute myeloid leukemia.